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The vitamin A-related retinoids have recently been
shown to be involved in the development of the central
nervous system, both in specifying position along the
head-to-tail axis and in the development of a specific
subset of motor neurons.
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How is it that we have lots of motor neurons of the right
types and in the right places in the spinal cord to innervate
our limbs? This difficult question has been the subject of
neurobiological research since the last century. Progress in
answering the question has not been notably rapid, but
now three recent papers [1–3] have reported definite
progress, with results that emphasise the role that retinoic
acid — the biologically active vitamin A derivative — plays
in specifying positional identity along the head-to-tail axis
of the central nervous system (CNS) and determining
motor neuron character in the spinal cord.
Retinoic acid and the Hox code
In vertebrates, the familiar homeobox genes of the four Hox
clusters play a crucial role in informing cells of their position
along the head-to-tail axis of both the neural tube and the
adjacent mesoderm. The overlapping expression domains
of these genes are thought to generate a ‘Hox code’ [4] that
specifies positional identity (Figure 1). This notion is sup-
ported by the results of experiments involving loss-of-func-
tion Hox mutations or overexpression of Hox genes in the
mouse; these alterations have been found to result in trans-
formations of the identity of both vertebrae, which develop
from somites, and the segments of the hindbrain (known as
rhombomeres). But what establishes the Hox code?
Several observations have pointed to retinoic acid as a key
regulator of Hox gene expression. When embryos develop
in either the absence of retinoic acid or the presence of
excess retinoic acid, then the Hox code and the resulting
anatomy are radically altered [5,6]. Furthermore, the
upstream control regions of several Hox genes, notably
those expressed in the developing hindbrain, have been
shown to possess retinoic acid response elements
(RAREs, see below). Before considering the new evidence
that retinoic acid plays an important part in specifying
positional identity in the spinal cord, it is worth reviewing
what we know about the biochemistry and biological
action of retinoic acid.
Retinoic acid is derived from retinol (vitamin A) by
oxidation, first to retinaldehyde by a retinol dehydroge-
nase and then to retinoic acid by a retinal dehydrogenase
(RALDH). Retinoic acid exists in various forms: all-
trans-retinoic acid, 9-cis-retinoic acid and 4-oxo-retinoic
acid are the most common ones. The molecule acts at the
level of the nucleus by binding to retinoic acid receptors,
which are nuclear transcription factors. Two classes of
retinoic acid receptor have been identified: the RARs —
RARα, RARβ and RARγ — bind either all-trans-retinoic
acid or 9-cis-retinoic acid, whereas the RXRs — RXRα,
Figure 1
Drawing of the parts of the CNS and the anterior somites of an early
chick embryo to show the overlapping expression domains of some
Hox genes that are thought to constitute a developmental ‘Hox
code’. The CNS consists of the forebrain, midbrain, hindbrain and
spinal cord. The hindbrain is made up of a series of seven bulges
known as rhombomeres (r1–r7). The somites (s1–s8) are pairs of
segmented mesoderm either side of the spinal cord. Orange bar,
Hoxb2 expression; green bar, Hoxb3 expression; yellow bar, Hoxb4
expression; purple bar, Hoxb5 expression.
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RXRβ and RXRγ — bind only 9-cis-retinoic acid. The
RARs and RXRs act on retinoic-acid-responsive genes by
heterodimerizing and binding to specific upstream
sequences — the above-mentioned RAREs — thereby
activating (or repressing) transcription. Different genes
have slightly different RAREs, and the binding of differ-
ent receptor heterodimers to different RAREs generates
specificity. All of these players appear in the papers 
highlighted here [1–3].
Where does retinoic acid come from in the embryo?
In addition to retinoic acid, two other manipulations have
been shown to alter the Hox code of the developing hind-
brain. One manipulation involves the grafting of somites
next to the developing hindbrain neuroepithelium [7], and
the other involves the grafting of the hindbrain neuro-
epithelium itself to a more posterior location [8].
Experiments of the latter type have suggested that there
is a source of retinoic acid in the spinal cord which diffus-
es anteriorly into the hindbrain to set up the Hox code
there [8]. The former type of experiment has now been
taken further by Gould et al. [1], using the Hoxb4 gene as
an analytical marker. Hoxb4 has an early expression bound-
ary in the posterior hindbrain, at the level of rhombomere
6/7, which is opposite somite 1. The control regions of
Hoxb4 include an early neural enhancer containing an
RARE; mutations in this RARE abolished the normal sites
of Hoxb4 expression, demonstrating the importance of a
source of endogenous retinoic acid. But where does the
retinoic acid come from to set up the domain of early
Hoxb4 expression? 
This was investigated by culturing pieces of embryonic
tissue from a transgenic line expressing a marker gene
under the control of the Hoxb4 early neural enhancer.
Normal expression was found to begin at somite stages
9/10, but when the presumptive hindbrain neuro-
epithelium from these early somite stages was cultured in
isolation transgene expression failed to occur. When the
same neuroepithelium was cultured with somites 2–5,
which it would neighbour in the intact mouse, normal
expression occurred. More posterior somites were found to
work even better. This somite-derived inducing signal
could be mimicked by retinoic acid and prevented by prior
treatment of the somites with an inhibitor of retinoic acid
synthesis, making retinoic acid an excellent candidate for
being the inducing molecule. Transfilter experiments
showed that the inducing factor actually had a molecular
weight of 10–200 kDa, suggesting that either the retinoic
acid is bound to a higher molecular weight factor that acts
as a kind of chaperone, or that the high-molecular weight
factor is downstream of the primary inducer. 
Most amazingly, Gould et al. [1] also demonstrated that
RAREs interpret positional information along the head-
to-tail axis. When the Hoxb4 RARE was swapped with
the RARE from the Hoxb1 gene, which normally has a
more anterior boundary of expression than Hoxb4, then
the marker transgene was expressed in a wider domain,
with a more anterior border resembling that of the
endogenous Hoxb1 gene. This means that distinct
RAREs can determine the positions along the head-to-
tail axis of hindbrain Hox gene expression domains, and
very likely other genes too.
The conclusion from this work was thus that the domains
of Hox gene expression are established in the neuro-
epithelium by an inducer, the action of which involves
retinoic acid and the source of which is in the adjacent
mesoderm. This is precisely the same conclusion as has
been reached by another set of recent studies, aimed at
investigating a patterning event slightly further down the
neural tube in the developing spinal cord, namely the posi-
tioning of the limb-specific motor neurons.
Motor neuron location and subtype
The limb-specific motor neurons are found at the brachial
and lumbar levels of the neural tube, so that they can grow
into the adjacent developing limb buds (Figure 2a). This
aspect of position is also related both to retinoic acid and
the adjacent somites, exactly as in the case of the hindbrain
described above. It is known that, at the brachial and lum-
bar enlargements, there are peaks of retinoic acid produc-
tion [9,10], and that this is due to the presence in the motor
neurons of an enzyme, RALDH-2, which makes retinoic
acid [10,11]. Ensini et al. [12] discovered that, when
brachial (limb) level somites were moved posteriorly to
thoracic (non-limb) levels, then ectopic limb-specific
motor neurons were induced (Figure 2b). 
Sockanathan and Jessell [2] have now reported that
cultured thoracic cord could be induced to produce these
same limb-specific motor neurons by the addition of
retinoic acid. Thus, again, retinoic acid and somites share
the property of inducing changes in the neuroepithelium
of the CNS. Sockanathan and Jessell [2] have gone further,
however, in investigating the precise role of retinoic acid in
the generation of a subset of motor neurons. 
There are several subtypes of motor neuron. Medial motor
cells (MMCs) extend the whole length of the spinal cord
and innervate the muscles of the back and the ventral body
wall, whereas lateral motor cells (LMCs) are found only at
limb levels in the brachial and lumbar cord (Figure 2c).
Further, there are two classes of LMCs, those found
medially (LMCm), which innervate ventral limb muscles,
and those found laterally (LMCl), which innervate dorsal
limb muscles (Figure 2c). Each of these classes have 
previously been found to express a characteristic combina-
tion of LIM homeobox genes — forming a kind of ‘LIM
code’ analogous to the Hox code mentioned above — and
they can therefore be identified with certainty [13,14].
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Sockanathan and  Jessell [2] have confirmed that it is the
LMCs — both LMCLs and LMCMs — that express
RALDH-2, and that in the thoracic cord, which does 
not generate LMCs, no RALDH-2 is expressed. This is 
clearly a crucial decision, with regard to positional identity
along the head-to-tail axis, for the following reasons. When
brachial explants were cultured in retinoic acid or retinol,
the number of motor neurons was increased; more impor-
tantly, this was also observed when thoracic explants were
cultured in retinoic acid. 
But it was the type of motor neuron induced in these exper-
iments that was the key finding. When brachial explants
were cultured in the absence of retinoids, motor neurons
were still produced, but none were LMCLs. In the presence
of retinol or retinoic acid, however, LMCLs are produced.
Most importantly, thoracic explants — from non-limb levels
that normally have no LMCs — could also be induced to
produce LMCLs in the presence of retinoic acid. The pres-
ence of retinoic acid at limb levels is thus the determining
factor in the generation of the appropriate LMCs. This con-
clusion was reinforced by retrovirally misexpressing
RALDH-2 in the thoracic cord, which induced ectopic
motor neurons expressing the ‘LIM code-word’ for LMCL.
Two important findings came from a closer look at the
RALDH-2 and LIM gene expression patterns. Firstly,
some later-born cells expressing the LIM code-word for
LMCL were found medial to the lateral motor columns,
and these did not express RALDH-2. Sockanathan and
Jessell [2] thus suggest that becoming a LMCL neuron is
not a cell autonomous action, but involves retinoic acid sig-
nalling from earlier-born cells that express RALDH-2.
Secondly, in the RALDH-2-transfected thoracic cords,
most LMCL neurons did not themselves express
RALDH-2, so they must have been induced by adjacent
transfected cells. These observations suggest that the
RALDH-2-expressing cells are the sites of retinoic acid
production and act in a paracrine manner to influence the
developmental fate of neighbouring cells.
As in most developmental studies, these observations
emphasise the positive nature of signalling molecules, but
they also immediately pose the question of what stops all
cells from being positively affected by the signal.
Specifically, why do not all LMCs become LMCLs once
retinoic acid starts to be generated? Presumaby, LMCMs
express something that prevents them from being affected
by the surrounding retinoic acid, and the nature of such a
putative inhibitor is an issue for the future.
Which retinoid receptors?
In any biological system where retinoic acid is involved, we
need to know the mechanism of action and thus which of
the many retinoid receptors are involved, and motor neuron
development is no exception. As explained above, there are
two classes of retinoid receptors that bind to the RAREs of
retinoic-acid-responsive genes: the RARs and RXRs.
These receptors function as homodimers or heterodimers.
The RARs act as heterodimers with an RXR, whereas the
RXRs can act as either homodimers or heterodimers with
Figure 2
(a) Drawing of a later stage embryo, showing
the somites and, on the right-hand side, the
forelimbs and hindlimbs growing out. The
spinal cord at the limb levels (red) makes
special motor neurons (LMCs) and expresses
the enzyme RALDH-2, which catalyses 
production of retinoic acid. (b) When
somites from the limb levels are grafted to
the inter-limb region (purple arrow), then the
type of spinal cord characteristic of the limb
levels — defined in the studies described in
the text by production of LMCs and presence
of RALDH-2 — is induced. (c) Drawing of the
chick spinal cord to show the organisation of
motor columns.
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RARs or a range of other, related receptors. It is important
to consider whether both partners of a heterodimer need to
be liganded before the complex can be activated. In vitro,
the RXR can act as a silent (unliganded) partner [15] and
the endogenous ligand for the RXRs, 9-cis-retinoic acid, has
not been found in chick or mouse embryos, whereas all-
trans-retinoic acid is readily detectable. 
A common approach to this question is to use receptor-
specific agonists, to see whether simultaneous ligand 
activation of RARs and RXRs results in the synergistic 
promotion of a physiological response. Solomin et al. [3],
however, took a completely novel approach to demon-
strating ligand activation of the receptors in vivo, with
results that again pointed to motor neurons. They made
two effector constructs consisting of the ligand-binding
domain of either the RAR or the RXR fused to the yeast
transcription factor GAL4; the constructs were inserted
into a nestin expression vector, from which the fusion
proteins could be expressed specifically in the CNS of
transgenic mice. The authors also made a reporter con-
struct, to indicate where the retinoic acid receptors are
active in the transgenic mice, and, by inference, where
ligand is present at high enough concentration to activate
the receptors. The reporter construct consisted of the
LacZ gene, a promoter and GAL4-specific binding sites.
Thus, in the presence of the RAR or RXR ligand, GAL4
will be made from the effector construct, which will 
activate the reporter construct and make β-galactosidase
which can be visualised.
Solomin et al. [3] found that the RAR construct was
activated by day 10.5 of mouse embryogenesis in two now
familiar locations, the brachial and lumbar spinal cord,
where the forelimbs and hindlimbs were growing out. The
RXR construct was activated slightly later, by day 11, and
in precisely the same locations. Sections through the
embryos showed RAR activation to begin in the ventral
half of the neural tube, encompassing the developing
motor neurons, and then move dorsally. The pattern of
RXR activation was precisely the same, but half a day later.
This time delay means that, by the time the RXR is 
activated in the motor neurons, activation of the RAR has
already moved dorsally. These observations have two
important implications: first, that the RXR is unlikely to
act through RAR–RXR heterodimers, but rather through
another pathway with another heterodimerisation partner;
and second, that there are two waves of retinoid activity
during motor neuron development.
Prospects
The recent results reviewed above made a clear case that
retinoic acid is involved in positioning domains of gene
expression along the head-to-tail axis of the embryo, and in
the development of a specific subset of motor neurons. It
will be fascinating in the future to learn whether there is a
continuing requirement for retinoic acid in the maintenance
of subsets of neurons, and whether its absence might play a
role in the onset of neurodegenerative diseases, such as
motor neuron disease.
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